Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 56

Results For "safety"

1080 News Found

Zenara Pharma launches the first generic of Paxlovid for COVID-19 in India
News | September 12, 2022

Zenara Pharma launches the first generic of Paxlovid for COVID-19 in India

Pfizer’s Paxlovid is approved by US FDA for COVID treatment


Zydus Lifesciences acquires rights to market MonoFerric injections in India and Nepal
News | September 10, 2022

Zydus Lifesciences acquires rights to market MonoFerric injections in India and Nepal

MonoFerric, iron isomaltoside 1000 solution for injection/infusion, is a rapid, single dose IV iron developed to reduce the number of infusions


Allurion launches weight management solution in India
News | September 09, 2022

Allurion launches weight management solution in India

The Allurion Program is suited for people who are unable to achieve their weight-loss goals by dieting alone or for those who do not want to, or cannot, undergo invasive surgery or endoscopy


Panacea Biotec received US FDA communication for Baddi facility
Drug Approval | September 09, 2022

Panacea Biotec received US FDA communication for Baddi facility

The OAI classification implies that the USFDA expects further corrective actions and may withhold approval of any pending product applications or supplements filed from this facility till the outstanding observations are resolved


Evonik appoints Dr. Gaetano Blanda as Head of Animal Nutrition Business Line
People | September 08, 2022

Evonik appoints Dr. Gaetano Blanda as Head of Animal Nutrition Business Line

Blanda will be responsible for overseeing Evonik’s amino acids and functional feed additives business and the expansion of its precision livestock farming approach


Honeywell to collaborate with leading health providers to advance digitalization of healthcare globally
Digitisation | September 08, 2022

Honeywell to collaborate with leading health providers to advance digitalization of healthcare globally

Aimed at improving patient outcomes and increasing connectivity for more efficient monitoring In hospitals and homes


World’s first intra nasal vaccine iNCOVACC from Bharat Biotech receives approval
Drug Approval | September 07, 2022

World’s first intra nasal vaccine iNCOVACC from Bharat Biotech receives approval

iNCOVACC was developed in partnership with Washington University St. Louis, which had designed and developed the recombinant adenoviral vectored constructs and evaluated them in preclinical studies for efficacy


Mandaviya virtually lays Foundation Stone of NCDC branches in 6 states
Policy | September 07, 2022

Mandaviya virtually lays Foundation Stone of NCDC branches in 6 states

NCDC branches in States/UTs will provide a boost to Public Health Infrastructurewith prompt surveillance, rapid detection and timely monitoring of diseases enabling Early Interventions


Boehringer Ingelheim InPedILD Phase III trial showed encouraging results for both primary endpoints
Diagnostic Center | September 06, 2022

Boehringer Ingelheim InPedILD Phase III trial showed encouraging results for both primary endpoints

New data from Boehringer Ingelheim support the potential use of nintedanib in children and adolescents with fibrosing interstitial lung disease


InnoCare announces priority review of Orelabrutinib for the treatment of R/R MZL by NMPA
News | September 06, 2022

InnoCare announces priority review of Orelabrutinib for the treatment of R/R MZL by NMPA

Orelabrutinib is a highly selective BTK inhibitor developed by InnoCare for the treatment of cancers and autoimmune diseases.